Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Breast: Page 55
Photon-counting CT makes modality more effective for breast imaging
By
Kate Madden Yee
Tuesday, November 30 | 9:30 a.m.-10:30 a.m. | SSPH09-5 | Room TBAIn this Tuesday morning presentation, research findings will show how high-resolution photon-counting CT used with deep-learning image processing can expand the modality's role in breast cancer imaging.
November 15, 2021
Road to RSNA 2021: Women's Imaging Preview
By
Amerigo Allegretto
At RSNA 2021, attendees will have the chance to learn about new and improved ways to detect and diagnose breast cancers, screening methods that combine multiple imaging modalities, the role of artificial intelligence in reducing false positives and improving accuracy, the continued emergence of digital breast tomosynthesis, abbreviated breast MRI, and more.
November 15, 2021
AI model shows promise in detecting lesions from DBT data
By
Amerigo Allegretto
Wednesday, December 1 | 3:00 p.m.-4:00 p.m. | SSBR09-3 | Room TBAFinish your RSNA week off right with this presentation, in which researchers will discuss an artificial intelligence (AI) algorithm that detects lesions using datasets from digital breast tomosynthesis (DBT) exams.
November 15, 2021
Deep-learning tool triages women with decreased breast density
By
Amerigo Allegretto
Wednesday, December 1 | 3:00 p.m.-4:00 p.m. | SSBR09-4 | Room TBAIn this Wednesday talk, researchers will present findings from their study of nearly 2,700 women that used a convolutional neural network in predicting mammographic density percentage from MRI scans.
November 15, 2021
'Plug-and-play' AI method helps with microcalcifications on DBT
By
Amerigo Allegretto
Tuesday, November 30 | 9:30 a.m.-10:30 a.m. | SSPH09-6 | Room TBAResearchers will present results from a "plug-and-play" artificial intelligence (AI) algorithm that they say has the potential to improve detection of microcalcifications on digital breast tomosynthesis (DBT) images.
November 15, 2021
Consider breast thickness when measuring cancer risk
By
Amerigo Allegretto
Tuesday, November 30 | 8:00 a.m.-9:00 a.m. | SSBR05-6 | Room TBAIn this presentation, researchers will talk about their findings on distributing volumetric breast density across screening populations around the world for measuring risk.
November 15, 2021
Premenopausal women more affected by adding density to risk model
By
Amerigo Allegretto
Tuesday, November 30 | 8:00 a.m.-9:00 a.m. | SSBR05-5 | Room TBAIn this presentation, Dr. Stamatia Destounis from Elizabeth Wende Breast Care will talk about the effects of adding mammographic density to the Tyrer-Cuzick risk model.
November 15, 2021
AI reduces false positives on breast ultrasound
By
Amerigo Allegretto
Monday, November 29 | 3:00 p.m.-4:00 p.m. | SSBR04-6 | Room TBAResearchers will present their findings from a clinical trial that used artificial intelligence (AI) in an effort to reduce false positives on breast ultrasound.
November 15, 2021
Harmonic, subharmonic ultrasound characterizes breast lesions
By
Amerigo Allegretto
Monday, November 29 | 3:00 p.m.-4:00 p.m. | SSBR04-4 | Room TBAIn this presentation, Flemming Forsberg, PhD, from Thomas Jefferson University in Philadelphia will discuss characterizing breast lesions with 3D harmonic and subharmonic ultrasound.
November 15, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By
Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room TBAIn this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 15, 2021
Combining radiomics, AI with PET/MRI helps assess nodal status
By
Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room TBAHere, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 15, 2021
DBT continues to show promise a decade after commercial availability
By
Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSBR01-2 | Room TBAPresenters will give the verdict on whether digital breast tomosynthesis (DBT) has been a successful screening method since the first commercially available system was released in 2011.
November 15, 2021
Previous Page
Page 55 of 573
Next Page